News | January 15, 2026
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
The partnership will launch a Phase 1b cohort within Boehringer’s ongoing Beamion-BCGC1 trial
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The findings, from the SPACE study, paved the way for FDA approval of AJOVY for pediatric patients aged 6-17 years weighing 45 kilograms
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
Subscribe To Our Newsletter & Stay Updated
